TheraRadar

Pharma Intelligence, Simplified

← Back
Data updated: Mar 10, 2026

EGIS

Infectious DiseaseDermatology
Generics

EGIS is a generic drug manufacturer focused on Infectious Disease, Dermatology.

1997
Since
2
Drugs
-
Trials
6
Approved (2yr)

Key Drugs

No active drugs

Recent Activity

BUSPIRONE HYDROCHLORIDE 2025-10-06
Manufacturing (CMC)
PIROXICAM 2025-09-12
Labeling
BUSPIRONE HYDROCHLORIDE 2025-07-03
Manufacturing (CMC)
BUSPIRONE HYDROCHLORIDE 2025-04-08
Labeling
BUSPIRONE HYDROCHLORIDE 2024-07-26
Labeling
PIROXICAM 2024-07-08
Labeling
SEC Filings Pro
Loading...

Therapeutic Focus

Score weights: Approved drugs ×3, Phase 3 ×2, Phase 2 ×1, Phase 1 ×0.5

Infectious Disease 50%
0 drugs Phase 2: 1
Dermatology 50%
0 drugs Phase 2: 1

Pipeline Strength Pro

Loading...

Competitors Pro

Pfizer big-pharma
Infectious Disease, Dermatology
Baxter specialty
Infectious Disease, Dermatology
B BRAUN specialty
Infectious Disease, Dermatology
COSETTE other
Dermatology, Infectious Disease
BAUSCH AND LOMB specialty
Infectious Disease, Dermatology